Brian E Dixon
Overview
Explore the profile of Brian E Dixon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frutos A, Cleary S, Reeves E, Ahmad H, Price A, Self W, et al.
MMWR Morb Mortal Wkly Rep
. 2025 Feb;
74(6):83-90.
PMID: 40014791
Annual influenza vaccination is recommended for all persons aged ≥6 months in the United States. Interim influenza vaccine effectiveness (VE) was calculated among patients with acute respiratory illness-associated outpatient visits...
2.
Williams K, Rahurkar S, Grannis S, Schleyer T, Dixon B
BMC Med Inform Decis Mak
. 2025 Feb;
25(1):97.
PMID: 39994604
Background: Motivated by the Triple Aim, US health care policy is expanding its focus from individual patient care to include population health management. Health Information Exchanges are positioned to play...
3.
Rajamani S, Leider J, Gunashekar D, Dixon B
J Am Med Inform Assoc
. 2025 Feb;
PMID: 39936849
Objective: Modernizing and strengthening the US public health data and information infrastructure requires a strong public health informatics (PHI) workforce. The study objectives were to characterize existing PHI specialists and...
4.
Rowley E, Mitchell P, Yang D, Lewis N, Dixon B, Vazquez-Benitez G, et al.
JMIR Form Res
. 2025 Jan;
9:e58981.
PMID: 39869907
Background: Real-world COVID-19 vaccine effectiveness (VE) studies are investigating exposures of increasing complexity accounting for time since vaccination. These studies require methods that adjust for the confounding that arises when...
5.
6.
Tenforde M, Reeves E, Weber Z, Tartof S, Klein N, Dascomb K, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39656838
Background: The 2023-2024 influenza season had predominant influenza A(H1N1)pdm09 virus activity, but A(H3N2) and B viruses co-circulated. Seasonal influenza vaccine strains were well-matched to these viruses. Methods: Using health care...
7.
Payne A, Watts J, Mitchell P, Dascomb K, Irving S, Klein N, et al.
Lancet
. 2024 Oct;
404(10462):1547-1559.
PMID: 39426837
Background: Respiratory syncytial virus vaccines first recommended for use during 2023 were efficacious against lower respiratory tract disease in clinical trials. Limited real-world data regarding respiratory syncytial virus vaccine effectiveness...
8.
Li P, Spector E, Alkhuzam K, Patel R, Donahoo W, Bost S, et al.
Diabetes Obes Metab
. 2024 Sep;
27(1):102-110.
PMID: 39344840
Aim: To develop an automated computable phenotype (CP) algorithm for identifying diabetes cases in children and adolescents using electronic health records (EHRs) from the UF Health System. Materials And Methods:...
9.
Ciesla A, Lazariu V, Dascomb K, Irving S, Dixon B, Gaglani M, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae481.
PMID: 39286032
Pregnant people face increased risk of severe COVID-19. Current guidelines recommend updated COVID-19 vaccination (2023-2024) for those aged ≥6 months, irrespective of pregnancy status. To refine recommendations for pregnant people,...
10.
Jones R, Andrews J, Dalton A, Dixon B, Dzomba B, Fernando S, et al.
BMC Public Health
. 2024 Aug;
24(1):2345.
PMID: 39210333
Background: Track PCC includes five geographic surveillance sites to conduct standardized population-based surveillance to estimate and track Post-COVID Conditions (PCC) by age, sex, race/ethnicity, geographic area, severity of initial infection,...